#China #Chongqing #SWS Medical #Blood Purification #ERA Congress

SWS Medical Presents Next-Generation Blood Purification Technologies at ERA 2026

SWS Medical is poised to showcase its latest advancements in blood purification at the ERA Congress 2026, occurring in Glasgow from June 3 to 6. This prominent event will see SWS Medical welcoming nephrologists, industry leaders, and partners at Booth D-350, where they will introduce their next-generation blood purification solutions tailored for dialysis and critical care.

With a robust foundation in research and development, manufacturing, and global distribution, SWS Medical continues to lead in the international market for dialysis and critical care blood purification systems. At this year’s ERA Congress, the company will present their groundbreaking dialysis and Continuous Renal Replacement Therapy (CRRT) platforms, engineered to enhance intelligent automation, streamline workflow efficiency, and deliver integrated therapy.

Among the highlighted products are the SWS-4000 and SWS-6000 series, two of the leading dialysis platforms in China, which held an estimated 20% market share in the country’s dialysis machine sector as of 2025. The flagship SWS-6000 model stands out as the sole dialysis machine in China possessing certified monitoring for critical treatment parameters. Meanwhile, the SWS-4000 is designed with an Online Hemodiafiltration (HDF) system aimed at producing sterile fluid, thereby enhancing patient safety and treatment efficiency through intelligent monitoring and automation.

Additionally, SWS Medical’s SWS-5000 model, renowned as China's top CRRT machine for the past three years, is an award-winning all-in-one platform designed for multi-organ blood purification therapies, addressing renal, hepatic, cardiac, pulmonary, and pancreatic health concerns. This machine signifies a leap in technology, promoting integrated treatment solutions for complex medical conditions.

The company’s offerings also include advanced dialyzers produced with proprietary pre-vacuum pressure steam sterilization methods, assuring high solute clearance rates and dependable ultrafiltration performance. Other innovative components comprise dialysis fluid filters and hemoperfusion cartridges, further broadening the spectrum of blood purification therapies available to healthcare providers.

An essential part of SWS Medical’s connected-care initiative, the Integrated Management Platform facilitates robust communication among dialysis centers, clinicians, and patients. This system integrates various tools, including a Data Hub, Patient Card, and a management system for hemodialysis, transforming data management into a framework for safer and smarter healthcare delivery.

Headquartered in Chongqing, China, SWS Medical is a publicly traded entity (STAR Market, SSE 688410) dedicated to innovations in blood purification solutions for dialysis and critical care applications. The company plays a pivotal role in advancing the blood purification industry in China, leading initiatives such as the China Blood Purification Industry Technology Innovation Strategic Alliance, which helps shape national standards.

SWS Medical’s commitment to quality is reflected in their adherence to international certifications, including CE marking and ISO 13485:2016 compliance, ensuring that their products meet global regulatory requirements.

As SWS Medical continues to innovate and expand its footprint internationally, their participation at the ERA Congress 2026 symbolizes both a demonstration of cutting-edge technology and a commitment to improving patient outcomes across the globe. For more information about their initiatives and products, visit swsdialysis.com.